<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Chromatin TADs &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/chromatin-tads/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 26 Jan 2026 12:45:21 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Chromatin TADs &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>M6A Modification Influences Chromatin TADs in MLLr+ AML</title>
		<link>https://bioengineer.org/m6a-modification-influences-chromatin-tads-in-mllr-aml/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 26 Jan 2026 12:44:53 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Chromatin TADs]]></category>
		<category><![CDATA[Epitranscriptomics]]></category>
		<category><![CDATA[Kanser terapötikleri **Açıklama:** 1. **m6A modifikasyonu:** Çalışmanın ana konusu olan RNA modifikasyonu. 2. **TAD bütünlüğü:** m6A'nın etk]]></category>
		<category><![CDATA[m6A modification]]></category>
		<category><![CDATA[m6A modifikasyonu]]></category>
		<category><![CDATA[METTL3-YTHDC1 axis]]></category>
		<category><![CDATA[METTL3-YTHDC1 ekseni]]></category>
		<category><![CDATA[MLL-rearranged AML]]></category>
		<category><![CDATA[MLLr+AML]]></category>
		<category><![CDATA[TAD bütünlüğü]]></category>
		<guid isPermaLink="false">https://bioengineer.org/m6a-modification-influences-chromatin-tads-in-mllr-aml/</guid>

					<description><![CDATA[In an exciting new study published in Molecular Cancer, researchers have uncovered the intricate relationship between RNA modifications and chromatin architecture, highlighting the crucial role of the METTL3-YTHDC1 axis. The team, led by Fu et al., delves into how the addition of N6-methyladenosine (m6A) to RNA molecules influences the integrity of topologically associating domains (TADs) [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">321067</post-id>	</item>
	</channel>
</rss>
